Christopher Abbosh

2.0k total citations
8 papers, 83 citations indexed

About

Christopher Abbosh is a scholar working on Surgery, Cancer Research and Molecular Biology. According to data from OpenAlex, Christopher Abbosh has authored 8 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Christopher Abbosh's work include Cancer Genomics and Diagnostics (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Neuropeptides and Animal Physiology (2 papers). Christopher Abbosh is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Neuropeptides and Animal Physiology (2 papers). Christopher Abbosh collaborates with scholars based in United Kingdom, United States and Denmark. Christopher Abbosh's co-authors include William Gray, Malik Zaben, Anan Shtaya, Ashley K. Pringle, Anthony J. Harmar, Charles Swanton, W. John Sheward, Mads Agerbæk, Jørgen Bjerggaard Jensen and Daniel Stetson and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Neurochemistry.

In The Last Decade

Christopher Abbosh

8 papers receiving 83 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Abbosh United Kingdom	3	47	33	32	10	9	8	83
Gizem Inak Germany	5	34 0.7×	69 2.1×	22 0.7×	7 0.7×	3 0.3×	8	104
Konstantinos Kyriakidis Greece	5	34 0.7×	55 1.7×	9 0.3×	12 1.2×	21 2.3×	14	127
Georg Ziegler Germany	6	21 0.4×	64 1.9×	10 0.3×	6 0.6×	12 1.3×	18	116
Florence Vachiéry-Lahaye France	6	24 0.5×	20 0.6×	27 0.8×	4 0.4×	3 0.3×	13	79
Daniel Hechler Germany	5	40 0.9×	51 1.5×	24 0.8×	5 0.5×	3 0.3×	5	140
Elke Stappers Belgium	4	32 0.7×	82 2.5×	37 1.2×	23 2.3×	3 0.3×	5	127
Stephanie Mok United States	2	30 0.6×	76 2.3×	17 0.5×	9 0.9×	4 0.4×	2	114
Jessica Cassin United States	5	72 1.5×	83 2.5×	53 1.7×	6 0.6×	2 0.2×	8	172
Britta Eiberger Germany	6	19 0.4×	49 1.5×	14 0.4×	12 1.2×	34 3.8×	8	109
Adel Qalieh United States	6	13 0.3×	83 2.5×	12 0.4×	10 1.0×	3 0.3×	6	135

Countries citing papers authored by Christopher Abbosh

Since Specialization

Citations

This map shows the geographic impact of Christopher Abbosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Abbosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Abbosh more than expected).

Fields of papers citing papers by Christopher Abbosh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Abbosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Abbosh. The network helps show where Christopher Abbosh may publish in the future.

Co-authorship network of co-authors of Christopher Abbosh

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Abbosh. A scholar is included among the top collaborators of Christopher Abbosh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Abbosh. Christopher Abbosh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Juul, Randi Istrup, Iver Nordentoft, Karin Birkenkamp‐Demtröder, et al.. (2025). Low T cell diversity associates with poor outcome in bladder cancer: A comprehensive longitudinal analysis of the T cell receptor repertoire. Cell Reports Medicine. 6(5). 102101–102101. 1 indexed citations

Goldstein, Jordan, Christopher Abbosh, Ash A. Alizadeh, Maximilian Diehn, & David M. Kurtz. (2024). Abstract 986: Mathematical modeling of ctDNA dynamics to predict utility of ultrasensitive MRD assays in early stage non-small cell lung cancer (NSCLC). Cancer Research. 84(6_Supplement). 986–986. 1 indexed citations

Nordentoft, Iver, Randi Istrup Juul, Karin Birkenkamp‐Demtröder, et al.. (2024). Abstract 5216: Peripheral T cell receptor repertoire diversity is associated with outcome in bladder cancer. Cancer Research. 84(6_Supplement). 5216–5216. 1 indexed citations

Nordentoft, Iver, Randi Istrup Juul, Karin Birkenkamp‐Demtröder, et al.. (2024). Abstract PR003: T cell receptor repertoire and diversity are prognostic markers in bladder cancer. Clinical Cancer Research. 30(10_Supplement). PR003–PR003. 1 indexed citations

Stetson, Daniel, Gregory T. Jones, Giovanni Marsico, et al.. (2023). Abstract 3384: Evaluation of a tumor informed MRD assay with contrived breast cancer samples. Cancer Research. 83(7_Supplement). 3384–3384. 1 indexed citations

Abbosh, Christopher & Charles Swanton. (2021). ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors. PLoS Medicine. 18(10). e1003771–e1003771. 9 indexed citations

Abbosh, Christopher, et al.. (2011). GalR2/3 mediates proliferative and trophic effects of galanin on postnatal hippocampal precursors. Journal of Neurochemistry. 117(3). 425–436. 33 indexed citations

Zaben, Malik, W. John Sheward, Anan Shtaya, et al.. (2009). The Neurotransmitter VIP Expands the Pool of Symmetrically Dividing Postnatal Dentate Gyrus Precursors via VPAC2 Receptors or Directs Them Toward a Neuronal Fate via VPAC1 receptors. Stem Cells. 27(10). 2539–2551. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact